Jump to content

IRCofCA/NovaRx NSCLC Lucanix research study

Guest alexl

Recommended Posts

IRCC is actively working with NovaRx to enroll patients in a research study of Lucanix, an investigational lung cancer vaccine. This vaccine is currently in Phase III trials. You can reach them at (877) 680-IRCC (4722) and they can answer most if not all of your questions about NSCLC and if your loved one will qualify. Hope this helps.

Link to comment
Share on other sites

Join the conversation

You can post now and register later. If you have an account, sign in now to post with your account.

Reply to this topic...

×   Pasted as rich text.   Restore formatting

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

  • Create New...

Important Information

By using this site, you agree to our Terms of Use. We have placed cookies on your device to help make this website better. You can adjust your cookie settings, otherwise we'll assume you're okay to continue.